Skip to main content

Table 1 Molecular characteristics and drug resistance of cell lines

From: Rational development of synergistic combinations of chemotherapy and molecular targeted agents for colorectal cancer treatment

Cell lines

KRAS

BRAF

p53

PI3K

Drug resistance

HCT116

G13D

wt

wt

H1047R

EGFRi

HCT116-SN6

G13D

wt

wt

H1047R

SN38/EGFRi

HCT116-SN50

G13D

wt

wt

H1047R

SN38/EGFRi

SW480

G12 V

wt

R273H/P309S

wt

EGFRi

LS174T

G12D

wt

wt

H1047R

EGFRi

HT29

wt

V600E

R273H

wt

EGFRi

SW48

wt

wt

wt

wt

none

  1. Abbreviations: wt wild type, EGFRi EGFR inhibitors